Publications by authors named "Maximillian G Posch"

Claim this Profile
E
Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.
Victoria E R Parker, Thuong Hoang, Heike Schlichthaar, Fraser W Gibb, Barbara Wenzel, Maximillian G Posch

Diabetes Obes Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study.
Philip D Ambery, Sebastian Klammt, Maximillian G Posch, Marcella Petrone, Wenji Pu

Br J Clin Pharmacol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
C Michael Gross, Andreas Perrot, Christian Geier, Maximillian G Posch, Sabine Hassfeld

J Invasive Cardiol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-stage heart failure with multiple intracardiac thrombi: a rescue strategy.
Maximillian G Posch, Larry O Thompson, Michael M Koerner, Mehmet H Akay, George P Noon

Tex Heart Inst J· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis